HomeNews & storiesNew study: Funding for key populations affected by HIV and AIDS “way off track”
HomeNews & storiesNew study: Funding for key populations affected by HIV and AIDS “way off track”
New study: Funding for key populations affected by HIV and AIDS “way off track”
Last updated on: 05 March 2024
Funding for key populations affected by HIV and AIDS “way off track”…
This is one of the main conclusions from the first ever study into global funding for key populations, released today at the HIV2020 conference by Aidsfonds through the Bridging the Gaps and PITCH partnerships.
Fast-Track or Off Track: how insufficient funding for key populations jeopardises ending AIDS by 2030
Funding for key populations affected by HIV and AIDS “way off track” with only 2% of money for HIV programmes targeting them.
This is especially alarming as key populations and their partners account for more than half of all the new HIV infections globally.
This study was commissioned by Aidsfonds through the Bridging the Gaps and PITCH partnerships.
The research looks into the funding towards HIV programming for gay and bisexual men and other men who have sex with men, transgender people, sex workers and people who inject drugs in low and middle income countries between 2016-2018, and compares this against funding for the overall HIV response.
There is a staggering gap of 80% between the budget required for key populations and the amount made available
From Brussels to the World: Europe’s Power to Save Lives
From Brussels to the World: Europe’s Power to Save Lives
Investing €800 million in the Global Fund doesn't just prevent and treat deadly diseases - it secures the future for up to 1.2 million people facing AIDS, tuberculosis and malaria.
That's more than the entire population of Brussels. This is the impact of European action.
330 organisations call for EC pledge ahead of Global Fund board meeting
330 organisations call for EC pledge ahead of Global Fund board meeting
On November 21, donors fell short of the Global Fund’s USD 18 billion target - a disappointing outcome at a time when increased support for HIV, TB and malaria is urgently needed.
Now, 330 organisations worldwide are urging the European Commission to confirm a €800 million pledge ahead of the February 2026 Board Meeting. This would help ensure timely funding for country programmes and unlock €400 million in US matching funds.
The Nov. 21 outcome fell short, but a stronger result is still possible - and the European Commission and EU Member States can play a key role, in line with Europe’s leadership in global health.